US 11179467
Exenatide modifier and use thereof
granted A61KA61K38/00A61K38/26
Quick answer
US patent 11179467 (Exenatide modifier and use thereof) held by BrightGene Bio-Medical Technology Co., Ltd. expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BrightGene Bio-Medical Technology Co., Ltd.
- Grant date
- Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/00, A61K38/26, A61K47/14, A61P